BJ Bioscience Inc.

Strong R&D and innovation capabilities
Rapid antibody screening platform
Innovative protein engineering
Global footprint with discovery laboratories in both China and USA
Rich and balanced pipeline
Eight products in pipeline, one has entered Phase I clinical development in the USA
Covers 3 major areas of diseases: cancer, infectious diseases and autoimmune diseases
Adequate backups to mitigate R&D risk
Excellent Executive Team and Advisory Committee
Members have extensive R&D experience from China and abroad
Complimentary expertise covering entire R&D process
Key members have successful out-licensing experience

Company Profile

BJ Bioscience Inc. is a biotechnology company dedicated to discover and develop next generation of innovative biopharmaceuticals for global market. It was founded by a groups of returnees with many years of experience in pharmaceutical R&D and complimentary expertise, including a review expert of National Key Innovative Drug R&D Projects, the National Health Commission of China. Based on its top notch trade secret protected antibody generation and screening technology, BJ Bioscience focuses its R&D in cancer, infectious and autoimmune diseases. With a vision of benefitting patients globally and strong financial support, BJ Bioscience builds its R&D capabilities in both China and the USA...

MORE →

News

——

BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors
HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the 'company') today announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001 program at NEXT ONCOLOGY in San Antonio, Texas.
Release time: 2019-12-10 08:42

MORE